Skip to main content

XTLB

Xtl Biopharmaceuticals Ltd

Company with tickers: XTLB

CIK
1023549
CUSIP
98386D307
Shares Outstanding
2,365,608
13F Activity (30d)
2 filings 1 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 6
Total Value: $764,964
Total Shares: 329,727

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 6 13F filers · Δ vs Sep 30, 2025
Top Holder
60.3%
Mar 2023 → Dec 2025 · range 60.3% – 87.6%
−27.3 pts
Top 5
99.5%
Mar 2023 → Dec 2025 · range 99.5% – 100.0%
−0.5 pts
Top 10
100.0%
Mar 2023 → Dec 2025 · range 100.0% – 100.0%
0.0 pts
HHI
4,276
Mar 2023 → Dec 2025 · range 4,276 – 7,759
Highly concentrated −3,483

Quarterly Activity

vs Sep 30, 2025
New
3
Increased
1
Decreased
1
Sold Out
1
Unchanged
1
Holder count: +2
Institutional value: -28.0%
Shares held: +45.3%

Top Buyers

vs Sep 30, 2025
Institution Added Now Holds Open

Top Sellers

vs Sep 30, 2025
Institution Sold Now Holds Open

Top New Positions

vs Sep 30, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Sep 30, 2025
Institution Previously Held Last Value (USD) Open
Showing 6 of 6
Export CSV
Holder Value (USD) % of 13F Shares Open